GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Gross-Profit-to-Asset %

Bioqual (Bioqual) Gross-Profit-to-Asset % : 35.57% (As of May. 2018)


View and export this data going back to . Start your Free Trial

What is Bioqual Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bioqual's annualized Gross Profit for the quarter that ended in May. 2018 was $8.73 Mil. Bioqual's average Total Assets over the quarter that ended in May. 2018 was $24.53 Mil. Therefore, Bioqual's annualized Gross-Profit-to-Asset % for the quarter that ended in May. 2018 was 35.57%.


Bioqual Gross-Profit-to-Asset % Historical Data

The historical data trend for Bioqual's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Gross-Profit-to-Asset % Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.23 40.00 35.72 54.94 35.57

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.23 40.00 35.72 54.94 35.57

Competitive Comparison of Bioqual's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Bioqual's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioqual's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bioqual's Gross-Profit-to-Asset % falls into.



Bioqual Gross-Profit-to-Asset % Calculation

Bioqual's annualized Gross-Profit-to-Asset % for the fiscal year that ended in May. 2018 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: May. 2018 )/( (Total Assets (A: May. 2017 )+Total Assets (A: May. 2018 ))/ count )
=8.725/( (22.76+26.305)/ 2 )
=8.725/24.5325
=35.57 %

Bioqual's annualized Gross-Profit-to-Asset % for the quarter that ended in May. 2018 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: May. 2018 )/( (Total Assets (Q: May. 2017 )+Total Assets (Q: May. 2018 ))/ count )
=8.725/( (22.76+26.305)/ 2 )
=8.725/24.5325
=35.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (May. 2018) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bioqual Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bioqual's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual (Bioqual) Business Description

Traded in Other Exchanges
N/A
Address
9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines